Change of Head of Internal Audit Unit of PT Pyridam Farma Tbk.
Based on the Decree of the Board of Directors of PT Pyridam Farma Tbk. (the “Company”) No. 129/PYFA-DIR/E/XI/2021 dated 19 November 2021 concerning the Dismissal and Appointment of the Head and/or Member of the Internal Audit Unit, and with reference
During the Second Quarter, Sales of PT. Pyridam Farma Tbk (PYFA) Up 147%
Jakarta, August 30, 2021 - PT. Pyridam Farma Tbk with the issuer name PYFA recorded sales of Rp. 105.1 billion in the second quarter of 2021, an increase of 147% compared to the second quarter of 2020. On a year-to-date
Information Disclosure
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk (“Company”) hereby inform that the Company and its affiliate intends to (i) purchase 27,385 shares
Public Expose Announcement
PUBLIC EXPOSE ANNOUNCEMENT PT PYRIDAM FARMA TBK The Board Directors of PT Pyridam Farma Tbk., domiciled in South Jakarta (hereinafter referred to as the “Company”) hereby invites the shareholders to attend the Electronic Public Expose (“Public Expose”) of the company which will
PT. Pyridam Farma Tbk (PYFA) Creates #GerakanSejutaVitamin Campaign, Ready to Distribute Free Vitamins to Indonesian People
Jakarta, 30 July 2021 - Seeing the number of COVID-19 cases that are still worrying in Indonesia, PT. Pyridam Farma Tbk (PYFA) has launched the #GerakanSejutaVitamin campaign and is committed to distributing a total of 1 million vitamin tablets to
The Increase of PT Bank OCBC NISP Tbk’s Loan Facility
Referring to Financial Service Authority (“OJK”) Regulation No. 17/POJK.04/2020 on Material Transaction and Business Activity Changes (“POJK No. 17/2020”), OJK Regulation No. 31/POJK.04/2015 on Disclosure of Information or Material Facts by Issuers or Public Companies and Indonesia Stock Exchange Regulation
Supporting the Highest Retail Price (HET) Decision From the Government, PT Pyridam Farma Tbk. Prioritize the Production of Azithromycin and D3-1000 for Accelerating Healing of COVID-19 Patients
[mkdf_inner_row_holder space_between_columns="normal" text_alignment=""][mkdf_inner_row_column column_size="6"][/mkdf_inner_row_column][mkdf_inner_row_column column_size="6"] Supporting the Highest Retail Price (HET) Decision From the Government, PT Pyridam Farma Tbk. Prioritize the Production of Azithromycin and D3-1000 for Accelerating Healing of COVID-19 Patients Jakarta, 14 July 2021 – Director of PT. Pyridam Farma
The Completion of the Subscription of New Shares in the Fullerton Health Indonesia Group by PT Pyfa Investama Medika
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk. (“Company”) hereby inform: Company is the 99.00% shareholder from the total issued and paid-up capital of
During the First Quarter, Sales of PT. Pyridam Farma Tbk (PYFA) Up 49%
Jakarta, June 3, 2021 - PT. Pyridam Farma Tbk with the issuer name PYFA recorded sales during the first quarter of 2021 increased by 49% compared to the first quarter of 2020. In addition, PYFA earned a net profit of
South Korean Conglomerate Purchased Shares in PT Pyridam Farma Tbk (PYFA)
Jakarta, 29 April 2021 - PT Aldiracita Sekuritas Indonesia has sold part of its ownership in PT Pyridam Farma Tbk (PYFA) to LG International Corp (LGI). LGI is part of the LG Group which is one of the largest conglomerates